AstraZeneca Sues FDA On Crestor Generics: Fighting A 'Foregone Conclusion'?
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is waging the same legal battle Otsuka lost last year, arguing pediatric orphan indication should block approvals of ANDAs.